For more than 30 years now, the name URSAPHARM has stood for the consistent transfer of innovative pharmaceutical concepts into successful medicinal products and medical devices. Today, URSAPHARM is a international operating medium-sized company, headquartered in Saarbrücken and ranks among the market leaders in ophthalmology in Germany. Special focus is placed on the treatment of the dry-eye syndrome (Sicca syndrome). URSAPHARM was the first to discover and explore the need to eliminate potentially harmful preservatives from multidose units of ophtalmological solutions. Medicinal products for use in general medicine complete the portfolio of URSAPHARM, like the enzyme preparation Bromelain-POS® for edema treatment.
Address
Industriestraße 35
D-66129 Saarbrücken
Telefon +49 (0) 6805 9292-0
Telefax +49 (0) 6805 9292-88
info@ursapharm.de
www.ursapharm.deYear of foundation
1974
Business activity
Pharmazeutischer Hersteller,
Augenheilkundliche
und allgemeinmedizinische Präparate,
Lohnfertiger
Employees
450
Business activity
Frank Holzer
Vorsitzender